RAUCK, MD, R. L.; BOOKBINDER, MD, S. A.; BUNKER, MD, T. R.; ALFTINE, MD, C. D.; GHALIE, MD, R.; NEGRO-VILAR, MD, PHD, A.; DE JONG, MD, E.; GERSHON, MD, S. A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial. Journal of Opioid Management, [S. l.], v. 2, n. 6, p. 325–333, 2006. DOI: 10.5055/jom.2006.0048. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/1151. Acesso em: 24 nov. 2024.